Published in Hospital and Nursing Home Week, April 20th, 2006
Funded by the National Institute of Mental Health (NIMH), the studies represent the second level of the Sequenced Treatment Alternatives to Relieve Depression trials (STAR*D2), providing long-term, "real world," comparative evidence that treatment with medication works for the most treatment-resistant depression.
"STAR*D2 sends a clear message of hope to the 15 to 20 percent of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week